Literature DB >> 421692

Superoxide dismutase and glutathione peroxidase in polymorphonuclear leucocytes.

M Rister, K Bauermeister, U Gravert, E Gladtke.   

Abstract

Superoxide dismutase (SOD) and glutathione peroxidase (GPX) protect aerobic organisms against the toxic superoxide anion and hydrogen peroxide, which are generated during phagocytosis by polymorphonuclear leucocytes (PMNs). PMNs of children with bacterial infections and with infectious hepatitis contained significantly elevated SOD activity, whereas GPX activity remained in the normal range. In contrast, PMNs of children with viral infections and rheumatoid arthritis exhibited a decreased SOD activity, while GPX activity was again unchanged. The children's age, sex or treatment did not effect the enzyme activities in PMNs. Since SOD generates bactericidal hydrogen peroxide and regulates the release of the toxic superoxide radical into the surrounding tissues, this study may add new understanding to the pathophysiological aspects of acute and chronic inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 421692     DOI: 10.1007/bf00442349

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  58 in total

1.  The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions.

Authors:  R L Baehner; S K Murrmann; J Davis; R B Johnston
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

2.  Subcellular distribution of superoxide dismutases in human neutrophils. Influence of myeloperoxidase on the measurement of superoxide dismutase activity.

Authors:  R F Rest; J K Spitznagel
Journal:  Biochem J       Date:  1977-08-15       Impact factor: 3.857

Review 3.  [Glutathione peroxidase: enzymology and biological aspects].

Authors:  L Flohé
Journal:  Klin Wochenschr       Date:  1971-06-15

4.  Superoxide dismutase isozymes in different human tissues, their genetic control and intracellular localization.

Authors:  G Beckman; E Lundgren; A Tärnvik
Journal:  Hum Hered       Date:  1973-04       Impact factor: 0.444

5.  Oxygen therapy and hyaline membrane disease: the effect of hyperoxia on pulmonary superoxide dismutase activity and the mediating role of plasma or serum.

Authors:  L Frank; A P Autor; R J Roberts
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

6.  [New aspects of oxygen toxicity].

Authors:  M Rister; R L Baehner
Journal:  Dtsch Med Wochenschr       Date:  1978-06-09       Impact factor: 0.628

7.  Induction of superoxide dismutase by molecular oxygen.

Authors:  E M Gregory; I Fridovich
Journal:  J Bacteriol       Date:  1973-05       Impact factor: 3.490

8.  The alteration of superoxide dismutase, catalase, glutathione peroxidase, and NAD(P)H cytochrome c reductase in guinea pig polymorphonuclear leukocytes and alveolar macrophages during hyperoxia.

Authors:  M Rister; R L Baehner
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  Effect of hyperoxia on superoxide anion and hydrogen peroxide production of polymorphonuclear leucocytes and alveolar macrophages.

Authors:  M Rister; R L Baehner
Journal:  Br J Haematol       Date:  1977-06       Impact factor: 6.998

10.  Superoxide dismutase in the rat and mouse as a function of age and longevity.

Authors:  E W Kellogg; I Fridovich
Journal:  J Gerontol       Date:  1976-07
View more
  3 in total

1.  Concanavalin A capping in polymorphonuclear leukocytes.

Authors:  M Rister; G Brucke; F Wegener; E Gladtke
Journal:  Eur J Pediatr       Date:  1980-12       Impact factor: 3.183

2.  [Superoxide-dismutase and superoxide-radical-release in rheumatoid arthritis (author's transl)].

Authors:  M Rister; K Bauermeister
Journal:  Klin Wochenschr       Date:  1982-06-01

3.  Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.